This article describes each treatment ... treat osteoarthritis of the knee. In clinical trials, 60 mg of duloxetine per day improved both pain and joint function after around four weeks of use.

To help reduce pain and slow joint damage, focus on eating more anti-inflammatory foods and limit those that may promote ...

Contineum (CTNM) announced authorization of its investigational new drug, or IND, application from FDA for PIPE-791 for the treatment of chronic pain associated with two separate indications, ...

Semaglutide can be doubly effective as a treatment for osteoarthritis. It helps patients lose weight while decreasing inflammation. These meds activate specific T cells, white blood cells key to ...

neck and lower back are the most commonly affected. Over-the-counter pain relievers and prescription medications are two common treatments for osteoarthritis. While there is no cure for ...

Pain lasting longer than three to six months is known as either chronic or persistent pain. Treatment can be important in preventing a transition from acute to chronic pain. One review of 5,233 people ...

As people age, joint and back pain often become ... the symptoms and knowing the treatment options can help older adults maintain mobility and independence. Osteoarthritis: When Joints Start ...

This article summarizes the available evidence on the management of patients with subacute or chronic low back pain ... independently of the chosen treatment, our daily concern remains chronic ...

Background: Often affecting knee joints, osteoarthritis (OA ... Adherence to arthritis medications is generally low. Intentional non-adherence, that is deliberate decision-making about the ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...